Department of Applied Science and Technology, Politecnico di Torino, C.so Duca degli Abruzzi 24 10129, Turin, Italy.
Faraday Discuss. 2017 Dec 4;205:271-289. doi: 10.1039/c7fd00140a.
In this work, SERS-based microfluidic PDMS chips integrating silver-coated porous silicon membranes were used for the detection and quantitation of microRNAs (miRNAs), which consist of short regulatory non-coding RNA sequences typically over- or under-expressed in connection with several diseases such as oncogenesis. In detail, metal-dielectric nanostructures which provide noticeable Raman enhancements were functionalized according to a biological protocol, adapted and optimized from an enzyme-linked immunosorbent assay (ELISA), for the detection of miR-222. Two sets of experiments based on different approaches were designed and performed, yielding a critical comparison. In the first one, the labelled target miRNA is revealed through hybridization to a complementary thiolated DNA probe, immobilized on the silver nanoparticles. In the second one, the probe is halved into shorter strands (half1 and half2) that interact with the complementary miRNA in two steps of hybridization. Such an approach, taking advantage of the Raman labelling of half2, provides a label-free analysis of the target. After suitable optimisation of the procedures, two calibration curves allowing quantitative measurements were obtained and compared on the basis of the SERS maps acquired on the samples loaded with several miRNA concentrations. The selectivity of the two-step assay was confirmed by the detection of target miR-222 mixed with different synthetic oligos, simulating the hybridization interference coming from similar sequences in real biological samples. Finally, that protocol was applied to the analysis of miR-222 in cellular extracts using an optofluidic multichamber biosensor, confirming the potentialities of SERS-based microfluidics for early-cancer diagnosis.
在这项工作中,我们使用基于 SERS 的微流控 PDMS 芯片,该芯片集成了镀银多孔硅膜,用于检测和定量 microRNAs(miRNAs)。miRNAs 是一类短的调节性非编码 RNA 序列,通常在与多种疾病(如肿瘤发生)相关的情况下过度或低表达。具体来说,根据生物协议对金属-介电纳米结构进行功能化,该协议是从酶联免疫吸附测定(ELISA)中改编和优化而来,用于检测 miR-222。设计并进行了两组基于不同方法的实验,进行了批判性比较。在第一种方法中,通过与固定在银纳米粒子上的互补硫醇化 DNA 探针杂交,揭示标记的靶标 miRNA。在第二种方法中,将探针分成较短的链(half1 和 half2),通过两步杂交与互补 miRNA 相互作用。这种方法利用 half2 的 Raman 标记,提供了对靶标的无标记分析。在适当优化程序后,获得了允许定量测量的两条校准曲线,并根据在加载有几种 miRNA 浓度的样品上获得的 SERS 图谱进行比较。通过检测与不同合成寡核苷酸混合的靶标 miR-222,证实了两步法检测的选择性,模拟了来自真实生物样品中类似序列的杂交干扰。最后,该方案应用于使用光流控多腔生物传感器分析细胞提取物中的 miR-222,证实了基于 SERS 的微流控技术在早期癌症诊断中的潜力。